Avon Foundation
16
1
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
18.8%
3 terminated/withdrawn out of 16 trials
76.9%
-9.6% vs industry average
0%
0 trials in Phase 3/4
70%
7 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
Role: collaborator
Study in Patients With Breast Cancer Leptomeningeal Metastasis
Role: collaborator
Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
Role: collaborator
Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
Role: collaborator
Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer
Role: collaborator
A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast Cancer
Role: collaborator
Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer
Role: collaborator
Pre-Surgical Intervention for Targeted Therapies for Breast Cancer
Role: collaborator
Reversing Therapy Resistance With Epigenetic-Immune Modification
Role: collaborator
Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
Role: collaborator
Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer
Role: collaborator
Vitamin D in Postmenopausal Women at High Risk for Breast Cancer
Role: collaborator
Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
Role: collaborator
Avon Foundation Program to Improve Quality of Life in Breast Cancer Survivors
Role: collaborator
The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers
Role: collaborator
Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer
Role: collaborator
All 16 trials loaded